AdLearn About HER2+ BreastCancer and A Combination Treatment Given As An Injection. Learn More About An Injection Treatment Option For Patients With HER2+ BreastCancer.
Types: Dosing & Administration, Important Safety Info, Patient Brochure
AdKomen has invested $25 million this past year in lifesaving research to end breastcancer. More than 1,200 potential breastcancer treatments are in the research pipeline.
